Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Study: Generative AI Model Reduces CXR Reading Time by 42 Percent
In addition to a significant reduction of X-ray reading time, researchers found the use of multimodal generative AI assessment led to enhanced detection of pleural lesions and widened mediastinal silhouettes.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
FDA Clears AI Software to Enhance CCTA Detection of Coronary Artery Disease
Through AI-powered assessment of coronary computed tomography angiography (CCTA) scans, the CaRi-Plaque software may provide improved clarity on the development of coronary plaques and luminal stenosis.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).